Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galapagos NV (NASDAQ:GLPG)

43.50
Delayed Data
As of Feb 05
 -4.53 / -9.43%
Today’s Change
21.59
Today|||52-Week Range
65.70
-30.82%
Year-to-Date

Today’s Trading

Previous close48.03
Today’s open46.69
Day’s range43.17 - 46.69
Volume134,653
Average volume (3 months)133,119
Market cap$1.7B
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-304.48%
Earnings growth (this year)--
Earnings growth (next 5 years)-77.90%
Revenue growth (last year)-49.96%
P/E ratio--
Price/Sales6.16
Price/Book5.28

Competitors

 Today’s
change
Today’s
% change
ACORAcorda Therapeutics ...-0.61-1.64%
LGNDLigand Pharmaceutica...-6.44-6.51%
USNAUSANA Health Science...-2.25-1.84%
CXRXConcordia Healthcare...-0.54-1.80%
Data as of 4:02pm ET, 02/05/2016

Financials

Next reporting dateMarch 4, 2016
EPS forecast (this quarter)-$0.88
Annual revenue (last year)$91.7M
Annual profit (last year)-$45.3M
Net profit margin-53.78%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
Onno van de Stolpe
Chief Financial Officer
Bart Filius
Corporate headquarters
Mechelen, Brussels Region

Forecasts

Partner Offers